Expanding the phenotypic and genotypic spectrum of patients with HGSNAT-related retinopathy

References

• Moro E. Lysosomal storage disorders: molecular basis and therapeutic approaches. Biomolecules. 2021;11(7):964. doi:10.3390/biom11070964.
   PubMed Web of Science ®Google Scholar
• Andrade F, Aldámiz-Echevarría L, Llarena M, Couce ML. Sanfilippo syndrome: overall review. Pediatr Int. 2015;57(3):331–8. doi:10.1111/ped.12636.
   PubMed Web of Science ®Google Scholar
• Hayasaka S. Lysosomal enzymes in ocular tissues and diseases. Surv Ophthalmol. 1983;27(4):245–58. doi:10.1016/0039-6257(83)90125-X.
   PubMed Web of Science ®Google Scholar
• Tomatsu S, Pitz S, Hampel U. Ophthalmological findings in mucopolysaccharidoses. J Clin Med. 2019;8(9):1467. doi:10.3390/jcm8091467.
   PubMed Web of Science ®Google Scholar
• Ashworth JL, Biswas S, Wraith E, Lloyd IC. The ocular features of the mucopolysaccharidoses. Eye (Lond). 2006;20(5):553–63. doi:10.1038/sj.eye.6701921.
   PubMed Web of Science ®Google Scholar
• Del Longo A, Piozzi E, Schweizer F. Ocular features in mucopolysaccharidosis: diagnosis and treatment. Ital J Pediatr. 2018;44(Suppl 2):125. doi:10.1186/s13052-018-0559-9.
   PubMedGoogle Scholar
• Sanfilippo SJPR, Good L, Langer RA. Mental retardation associated with acid mucopolysacchariduria (heparitin sulfate type). J Pediatr. 1963;63(4):837–8. doi:10.1016/S0022-3476(63)80279-6.
   Web of Science ®Google Scholar
• Lavery C, Hendriksz CJ, Jones SA. Mortality in patients with Sanfilippo syndrome. Orphanet J Rare Dis. 2017;12(1):168. doi:10.1186/s13023-017-0717-y.
   PubMedGoogle Scholar
• Hrebicek M, Mrázová L, Seyrantepe V, Durand S, Roslin NM, Nosková L, Hartmannová H, Ivánek R, Čížková A, Poupětová H, et al. Mutations in TMEM76* cause mucopolysaccharidosis IIIC (Sanfilippo C syndrome). Am J Hum Genet. 2006;79(5):807–19. doi:10.1086/508294.
   PubMed Web of Science ®Google Scholar
• Fan X, Zhang H, Zhang S, Bagshaw RD, Tropak MB, Callahan JW, Mahuran DJ. Identification of the gene encoding the enzyme deficient in mucopolysaccharidosis IIIC (Sanfilippo disease type C). Am J Hum Genet. 2006;79(4):738–44. doi:10.1086/508068.
   PubMed Web of Science ®Google Scholar
• Nagel L, Oliveira R, Pshezhetsky AV, Morales CR. HGSNAT enzyme deficiency results in accumulation of heparan sulfate in podocytes and basement membranes. Histol Histopathol. 2019;34(12):1377–85. doi:10.14670/HH-18-131.
   PubMed Web of Science ®Google Scholar
• Fedele AO. Sanfilippo syndrome: causes, consequences, and treatments. Appl Clin Genet. 2015;8:269–81. doi:10.2147/TACG.S57672.
   PubMedGoogle Scholar
• Comander J, Weigel-DiFranco C, Maher M, Place E, Wan A, Harper S, Sandberg M, Navarro-Gomez D, Pierce E. The genetic basis of pericentral retinitis pigmentosa—a form of mild retinitis pigmentosa. Genes (Basel). 2017;8(10):256. doi:10.3390/genes8100256.
   PubMed Web of Science ®Google Scholar
• Haer-Wigman L, Newman H, Leibu R, Bax NM, Baris HN, Rizel L, Banin E, Massarweh A, Roosing S, Lefeber DJ, et al. Non-syndromic retinitis pigmentosa due to mutations in the mucopolysaccharidosis type IIIC gene, heparan-alpha-glucosaminide N-acetyltransferase (HGSNAT). Hum Mol Genet. 2015;24(13):3742–51. doi:10.1093/hmg/ddv118.
   PubMed Web of Science ®Google Scholar
• Schiff ER, Daich Varela M, Robson AG, Pierpoint K, Ba‐Abbad R, Nutan S, Zein WM, Ullah E, Huryn LA, Tuupanen S, et al. A genetic and clinical study of individuals with nonsyndromic retinopathy consequent upon sequence variants in HGSNAT, the gene associated with Sanfilippo C mucopolysaccharidosis. Am J Med Genet C Semin Med Genet. 2020;184(3):631–43. doi:10.1002/ajmg.c.31822.
   PubMed Web of Science ®Google Scholar
• Van Cauwenbergh C, Van Schil K, Cannoodt R, Bauwens M, Van Laethem T, De Jaegere S, Steyaert W, Sante T, Menten B, Leroy BP, et al. arrEYE: a customized platform for high-resolution copy number analysis of coding and noncoding regions of known and candidate retinal dystrophy genes and retinal noncoding RNAs. Genet Med. 2017;19(4):457–66. doi:10.1038/gim.2016.119.
   PubMed Web of Science ®Google Scholar
• McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, Bach M. ISCEV standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol. 2015;130(1):1–12. doi:10.1007/s10633-014-9473-7.
   PubMed Web of Science ®Google Scholar
• Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405–24. doi:10.1038/gim.2015.30.
   PubMed Web of Science ®Google Scholar
• Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, Gu B, Hart J, Hoffman D, Jang W, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062–D7. doi:10.1093/nar/gkx1153.
   PubMed Web of Science ®Google Scholar
• Coutinho MF, Lacerda L, Prata MJ, Ribeiro H, Lopes L, Ferreira C, Alves S. Molecular characterization of Portuguese patients with mucopolysaccharidosis IIIC: two novel mutations in the HGSNAT gene. Clin Genet. 2008;74(2):194–5. doi:10.1111/j.1399-0004.2008.01040.x.
   PubMed Web of Science ®Google Scholar
• Feldhammer M, Durand S, Mrázová L, Boucher R-M, Laframboise R, Steinfeld R, Wraith JE, Michelakakis H, van Diggelen OP, Hřebíček M, et al. Sanfilippo syndrome type C: mutation spectrum in the heparan sulfate acetyl-CoA: α-glucosaminide N-acetyltransferase (HGSNAT) gene. Hum Mutat. 2009;30(6):918–25. doi:10.1002/humu.20986.
   PubMed Web of Science ®Google Scholar
• Feldhammer M, Durand S, Pshezhetsky AV. Protein misfolding as an underlying molecular defect in mucopolysaccharidosis III type C. PLoS One. 2009;4(10):e7434. doi:10.1371/journal.pone.0007434.
   PubMed Web of Science ®Google Scholar
• Martins C, de Medeiros PFV, Leistner-Segal S, Dridi L, Elcioglu N, Wood J, Behnam M, Noyan B, Lacerda L, Geraghty MT, et al. Molecular characterization of a large group of Mucopolysaccharidosis type IIIC patients reveals the evolutionary history of the disease. Hum Mutat. 2019;40(8):1084–100. doi:10.1002/humu.23752.
   PubMed Web of Science ®Google Scholar
• Matos L, Canals I, Dridi L, Choi Y, Prata MJ, Jordan P, Desviat LR, Pérez B, Pshezhetsky AV, Grinberg D, et al. Therapeutic strategies based on modified U1 snRNAs and chaperones for Sanfilippo C splicing mutations. Orphanet J Rare Dis. 2014;9(1):180. doi:10.1186/s13023-014-0180-y.
   PubMedGoogle Scholar
• Ruijter GJ, Valstar MJ, van de Kamp JM, van der Helm RM, Durand S, van Diggelen OP, Wevers RA, Poorthuis BJ, Pshezhetsky AV, Wijburg FA. Clinical and genetic spectrum of Sanfilippo type C (MPS IIIC) disease in the Netherlands. Mol Genet Metab. 2008;93(2):104–11. doi:10.1016/j.ymgme.2007.09.011.
   PubMed Web of Science ®Google Scholar
• Grondahl J. Pericentral retinal dystrophy. Acta Ophthalmol (Copenh). 1987;65(3):344–51. doi:10.1111/j.1755-3768.1987.tb08517.x.
   PubMed Web of Science ®Google Scholar
• Selmer KK, Grøndahl J, Riise R, Brandal K, Braaten Ø, Bragadottir R, Undlien DE. Autosomal dominant pericentral retinal dystrophy caused by a novel missense mutation in the TOPORS gene. Acta Ophthalmol. 2010;88(3):323–8. doi:10.1111/j.1755-3768.2008.01465.x.
   PubMed Web of Science ®Google Scholar
• Matsui R, Cideciyan AV, Schwartz SB, Sumaroka A, Roman AJ, Swider M, Huang WC, Sheplock R, Jacobson SG. Molecular heterogeneity within the clinical diagnosis of pericentral retinal degeneration. Invest Ophthalmol Vis Sci. 2015;56(10):6007–18. doi:10.1167/iovs.15-17174.
   PubMed Web of Science ®Google Scholar
• Hufnagel RB, Liang W, Duncan JL, Brewer CC, Audo I, Ayala AR, Branham K, Cheetham JK, Daiger SP, Durham TA, et al. Tissue-specific genotype–phenotype correlations among USH2A-related disorders in the RUSH2A study. Hum Mutat. 2022;43(5):613–24. doi:10.1002/humu.24365.
   PubMed Web of Science ®Google Scholar
• Igelman AD, Ku C, da Palma MM, Georgiou M, Schiff ER, Lam BL, Sankila E-M, Ahn J, Pyers L, Vincent A, et al. Expanding the clinical phenotype in patients with disease causing variants associated with atypical Usher syndrome. Ophthalmic Genet. 2021;42(6):664–73. doi:10.1080/13816810.2021.1946704.
   PubMed Web of Science ®Google Scholar
• Khateb S, Kowalewski B, Bedoni N, Damme M, Pollack N, Saada A, Obolensky A, Ben-Yosef T, Gross M, Dierks T, et al. A homozygous founder missense variant in arylsulfatase G abolishes its enzymatic activity causing atypical Usher syndrome in humans. Genet Med. 2018;20(9):1004–12. doi:10.1038/gim.2017.227.
   PubMed Web of Science ®Google Scholar
• Roosing S, van den Born LI, Sangermano R, Banfi S, Koenekoop RK, Zonneveld-Vrieling MN, Klaver CCW, van Lith-Verhoeven JJC, Cremers FPM, den Hollander AI, et al. Mutations in MFSD8, encoding a lysosomal membrane protein, are associated with nonsyndromic autosomal recessive macular dystrophy. Ophthalmology. 2015;122(1):170–9. doi:10.1016/j.ophtha.2014.07.040.
   PubMed Web of Science ®Google Scholar
• Xiang Q, Cao Y, Xu H, Yang Z, Tang L, Xiang J, Li J, Deng H, Yuan L. Novel MFSD8 variants in a Chinese family with nonsyndromic macular dystrophy. J Ophthalmol. 2021;2021:1–5.
   Web of Science ®Google Scholar
• Priluck AZ, Breazzano MP. Novel MFSD8 mutation causing non-syndromic asymmetric adult-onset macular dystrophy. Ophthalmic Genet. 2022;44(2):1–5. doi:10.1080/13816810.2022.2092758.
   Web of Science ®Google Scholar
• Chen FK, Zhang X, Eintracht J, Zhang D, Arunachalam S, Thompson JA, Chelva E, Mallon D, Chen SC, McLaren T, Lamey T. Clinical and molecular characterization of non-syndromic retinal dystrophy due to c.175G>A mutation in ceroid lipofuscinosis neuronal 3 (CLN3). Doc Ophthalmol. 2019;138(1):55–70. doi:10.1007/s10633-018-9665-7.
   PubMed Web of Science ®Google Scholar
• Wang F, Wang H, Tuan HF, Nguyen DH, Sun V, Keser V, Bowne SJ, Sullivan LS, Luo H, Zhao L, Wang X. Next generation sequencing-based molecular diagnosis of retinitis pigmentosa: identification of a novel genotype-phenotype correlation and clinical refinements. Hum Genet. 2014;133(3):331–45. doi:10.1007/s00439-013-1381-5.
   PubMed Web of Science ®Google Scholar
• Pichi F, Abboud EB, Ghazi NG, Khan AO. Fundus autofluorescence imaging in hereditary retinal diseases. Acta Ophthalmol. 2018;96(5):e549–e61. doi:10.1111/aos.13602.
   PubMed Web of Science ®Google Scholar
• Schmitz-Valckenberg S, Pfau M, Fleckenstein M, Staurenghi G, Sparrow JR, Bindewald-Wittich A, Spaide RF, Wolf S, Sadda SR, Holz FG, et al. Fundus autofluorescence imaging. Prog Retin Eye Res. 2021;81:100893.
   PubMed Web of Science ®Google Scholar
• Spaide R. Autofluorescence from the outer retina and subretinal space: hypothesis and review. Retina. 2008;28(1):5–35. doi:10.1097/IAE.0b013e318158eca4.
   PubMed Web of Science ®Google Scholar
• Eghbali A, Hassan S, Seehra G, FitzGibbon E, Sidransky E. Ophthalmological findings in Gaucher disease. Mol Genet Metab. 2019 May;127(1):23–7. doi:10.1016/j.ymgme.2019.02.002. Epub 2019 Feb 15. PMID: 31047801.
   PubMed Web of Science ®Google Scholar
• Berger-Plantinga EG, Vanneste JAL, Groener JEM, van Schooneveld MJ. Adult-onset dementia and retinitis pigmentosa due to mucopolysaccharidosis III-C in two sisters. J Neurol. 2004;251(4):479–81. doi:10.1007/s00415-004-0368-5.
   PubMed Web of Science ®Google Scholar